A/Prof Keith Lim
Clinical (Associate Professor)
Department of Medicine
52 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
CCL17 drives the expression of MMP9 and MMP13 expression via ERK1/2 and NF-κB signaling pathways in rheumatoid arthritis
DOI: 10.1016/j.cellsig.2026.1125512026
Journal article
Two decades of biologic and JAK inhibitor prescription patterns in the western region of Melbourne
DOI: 10.1111/imj.704552025
Journal article
Potential Significance of CCL17 in Psoriatic Arthritis
DOI: 10.1111/1756-185x.705262025
Journal article
Screening of the FDA-approved drug library identifies CCL17 inhibitors that block arthritic pain
DOI: 10.1038/s41598-025-12191-42024
Journal article
Regional ischaemic immune myopathy: unraveling a rare subtype of dermatomyopathy
DOI: 10.1136/bcr-2024-2608652024
Research grants (other domestic)
Biomarkers for Differentiating Spondyloarthritis and Osteoarthritis
2021
Research Grant
Biomarkers for Differentiating Spondyloarthritis and Osteoarthritis
RECENT SCHOLARLY WORKS
2024
Journal article
The cardiovascular risk of JAK inhibitors in treating rheumatic diseases
DOI: 10.1111/1756-185X.153082024
Journal article
AB0213 THE CARDIOVASCULAR RISK OF JAK INHIBITORS IN TREATING RHEUMATIC DISEASES
DOI: 10.1136/annrheumdis-2024-eular.21932023
Journal article
Epigenetic and transcriptional regulation of CCL17 production by glucocorticoids in arthritis
DOI: 10.1016/j.isci.2023.1080792023
Journal article
Targeting transcription factors for therapeutic benefit in rheumatoid arthritis
DOI: 10.3389/fimmu.2023.11969312022
Journal article
Myocarditis and pericarditis following mRNA vaccination in autoimmune inflammatory rheumatic disease patients: A single‐center experience
DOI: 10.1002/rai2.12042